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Background and Purpose Cerebral small vessel disease (SVDs) are related with large artery ath-
erosclerosis. However, the association between aortic atheroma (AA) and cerebral small vessel dis-
ease has rarely been reported. This study evaluated the relationship between presence and burden 
of AAs and those of SVDs in patients with acute ischemic stroke.
Methods We included 737 consecutive patients who underwent transesophageal echocardiogra-
phy (TEE) and brain magnetic resonance imaging (MRI) for evaluation of acute stroke. AA subtypes 
were classified as complex aortic plaque (CAP) and simple aortic plaque (SAP). Presence and burden 
of SVDs including cerebral microbleeds (CMBs), white matter hyperintensities (WMHs), perivascular 
spaces (PVSs), asymptomatic lacunar infarctions (ALIs), and total SVD score, were investigated.
Results AA was found by TEE in 360 (48.8%) patients including 11.6% with CAP and 37.2% with 
SAP. One or more types of SVDs was found in 269 (36.4%) patients. In multivariable analysis, pres-
ence of CMBs (odds ratio [OR] 4.68), high-grade WMHs (OR 3.13), high-grade PVSs (OR 3.35), and 
ALIs (OR 4.24) were frequent in patients with AA than those without AA. Each 1-point increase in to-
tal SVD score increased the odds of presence of CAP (OR 1.94, 95% confidence interval (CI) 1.44-
1.85) and SAP (OR 1.54, 95% CI 1.35-1.75).
Conclusions In this study, patients with AA frequently had cerebral SVDs. Larger burden of AA was 
associated with advanced cerebral SVDs. Our findings give an additional information for positive re-
lationship with systemic atherosclerosis and coexisting cerebral SVDs in acute ischemic stroke pa-
tients.
Keywords Aortic atheroma; Cerebral small vessel diseases; White matter hyperintensity 
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Introduction
Aortic atheroma (AA) is an atherosclerotic change in proximal 
and distal aorta or aortic arch. AA is regarded as high risk for oc-
currence and recurrence of ischemic stroke and poor long-term 
outcomes.1,2 Association between AA and cerebral large artery 
atherosclerosis had been confirmed not only in pathologic stud-
ies3 but also in clinical studies in patients with ischemic stroke.4,5 
Transesophageal echocardiography (TEE) is a useful tool for iden-
tification of AA. Presence of AA may indicate the presence of 
atherosclerosis in other vascular beds.4 
Cerebral small vessel diseases (SVDs) including cerebral micro-
bleeds (CMBs), white matter hyperintesities (WMHs), perivascu-
lar spaces (PVSs) and asymptomatic lacunar infarctions (ALIs) are 
associated with both ischemic and hemorrhagic stroke.6,7 Like 
AA, these SVDs had been reported that association of recurrence 
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and progression of ischemic stroke.8 
Patients with either AAs or SVDs frequently have common 
vascular risk factors including old age and hypertension.9,10 Apart 
from the association with stroke risk factors, AAs are known to 
make injury to brain via direct (such as embolic ischemic dam-
age) and/or indirect mechanism (such as increased arterial stiff-
ness by AAs).11,12 Even though many studies reported the associa-
tion between large artery atherosclerosis and SVDs,13 the studies 
for the relationship between AA and SVDs are limited.14 In this 
regards, we intended to investigate the relationship between 
presence and burden of AAs and those of coexisting SVDs in pa-
tients with acute ischemic stroke.
Methods
Subjects
Subjects for this study were drawn from consecutive patients 
with acute ischemic stroke who were registered in the Yonsei 
Stroke Registry.15 The Yonsei Stroke Registry is a prospective hos-
pital-based registry of patients with cerebral infarction or tran-
sient ischemic attack within 7 days after symptom onset.16 Dur-
ing admission, all patients were evaluated according to the stan-
dard stroke evaluation that includes brain imaging (computed 
tomography and/or magnetic resonance imaging [MRI]), vascular 
imaging studies (digital subtraction angiography, MR angiogra-
phy, or computed tomography angiography), plain chest X-ray, 
12-lead electrocardiography and cardiac echocardiography in-
cluding TEE. Stroke subtype was determined according to the 
Trial of Org 10172 in Acute Stroke Treatment (TOAST) classifica-
tion.17,18 Briefly, large artery atherosclerosis is defined as signifi-
cant (≥50%) stenosis of the large artery relevant to the acute 
infarction. The presence of complex aortic plaque (CAP) was 
considered as one form of large artery atherosclerosis. Cardio-
embolism is defined as at least one potential cardiac source of 
embolism based on the TOAST classification. A patient with lacu-
nar infarction should have one of the classic clinical lacunar 
syndromes and a relevant subcortical hemispheric or brain stem 
lesion with diameter <1.5 cm.16 Besides above method of the 
TOAST classification, we reclassified the TOAST classification. In 
that reclassification, CAPs were not considered as large artery 
atherosclerosis. The Institutional Review Board of Severance 
Hospital, Yonsei University Health System, approved this study 
and waived the need for patient informed consent because of 
the retrospective design and observational nature of the study.
Transesophageal echocardiography
TEE was performed within 2 weeks of initial stroke or transient 
ischemic attack. TEE was a component of standard evaluation 
for patients in the study hospital16 and was performed in all pa-
tients except for those with altered consciousness, progressing 
brain herniation, poor systemic condition, tracheal intubation, 
failure to introduce an esophageal transducer, or lack of in-
formed consent. Detailed method of performing TEE was de-
scribed in supplemental methods.19 Maximal thickness of plaques 
was used in this study. AAs were classified as CAP or simple aor-
tic plaque (SAP). CAPs consisted of plaques protruding into the 
lumen by ≥4 mm and mobile lesions located in the proximal 
aorta. SAPs were plaques <4 mm in the proximal aorta or 
plaques of any size located in the descending aorta.20 Patients 
who had both CAP and SAP were categorized into the CAP group 
because CAP is a more advanced form of AA and is regarded a 
potential cause of stroke. Two cardiologists who are experts in 
echocardiography interpreted the TEE results. In cases of discrep-
ancy, the final decision was made by consensus.3,19 
Risk factors and definitions of variables
The clinical variables including risk factors (hypertension, dia-
betes mellitus, hyperlipidemia, current smoking, coronary artery 
disease, the patient’s prior medication and metabolic syndrome) 
were described as based on previous studies. The detail definition 
of clinical variables was elucidated in supplementary methods.
MRI protocol and cerebral small vessel diseases
All MRI examinations were performed on a 3.0T MRI machine 
(Achieva 3.0T; Philips Medical Systems, Best, Netherlands or 
MAGNETOM 3.0T Trio; Siemens, Germany). Parameters of diffu-
sion-weighted imaging were time repetition/time echo=2,600-
6,500/42-70 ms, 2-mm inter-slice gap, field of view=230×230 
mm, and slice thickness=5 mm. Two b-values (0, 1,000) in six 
different directions of diffusion gradient (x, y, z, xy, yz, zx) were 
calculated. The fluid-attenuated inversion recovery image was 
performed with time repetition/time echo=9,000/120 ms, pixel 
spacing=0.449 mm/0.449 mm, field of view=230×230 mm, 
and slice thickness=5 mm. The gradient recalled echo images 
were obtained at time repetition/time echo=600/16 ms, pixel 
spacing=0.449 mm/0.449 mm, field of view=250×250 mm, 
and slice thickness=5 mm. 
Cerebral SVDs, including CMBs, WMHs, PVSs, and ALIs, were 
defined according to MRI findings (Figure 1). All lesions of SVDs 
should not be located in acute infarctions on diffusion-weighted 
imaging (Supplementary Figure 1, 2).21 CMBs were indicated as 
punctate hypointense lesion less than 10 mm in size and located 
in brain parenchyma.22 For this study, CMBs were classified as 
strictly lobar or non-lobar. Strictly lobar CMBs were defined as 
CMBs located only in the lobar location, whereas non-lobar 
CMBs were found in the non-lobar location, with or without one 
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or more lobar CMBs. Strictly lobar CMBs were defined when a 
patient had possible or probable cerebral amyloid angiopathy 
(CAA), as defined previously.23 We also assessed the severity of 
WMHs. The extent of WMHs was determined on the fluid-atten-
uated inversion recovery images of periventricular white matter 
or deep white matter according to Fazekas’ scoring system.24 A 
Fazekas score ≥2 in periventricular white matter and/or ≥2 in 
deep white matter was regarded as high-grade WMHs. PVSs 
were defined as punctate and/or linear hyperintense lesion in the 
basal ganglia on T2-weighted images. PVSs were <3 mm in size 
and were classified with the following scale: grade 0, no PVS; 
grade 1, 1-10 PVSs; grade 2, 11-20 PVSs; grade 3, 21-40 PVSs; 
and grade 4, ≥40 PVSs. High-grade PVSs were defined when le-
sions of grade 2-4 were found in the basal ganglia and centrum 
semiovale.25 ALIs were defined when the patients had no history 
of symptoms or signs of previous stroke. The imaging criterion of 
ALIs was one or more cavitary lesions with high-signal lesions on 
fluid-attenuated inversion recovery and T2-weighted images and 
low signal intensities on T1-weighted images. Size limitation of 
ALIs was ≥3 mm and <15 mm.26 According to a previous study, 
total SVD score was calculated by summation of 1 point for the 
presence of each of CMBs, high-grade WMHs, high-grade PVSs, 
or ALIs. The range of total SVD score was therefore 0-4.27 Two in-
vestigators who were blinded to the patient’s clinical information 
independently assessed the presence of SVD lesions. Interobserver 
agreement (kappa values) for presence of CMBs, high-grade 
WMHs, high-grade PVSs, and ALIs was 0.92, 0.84, 0.88, and 0.82, 
respectively. If there was disagreement, a final decision was 
reached by consensus.
Arterial stiffness
Arterial stiffness was evaluated by brachial-ankle pulse wave 
velocity (baPWV). The baPWV was measured using an automated 
device (VP-1000; Colin Co. Ltd, Komaki, Japan) while the patients 
were in the supine position. After resting for 5 minutes, the pulse 
wave was simultaneously detected in the upper arms and ankles. 
Time difference between the upper arm and ankle waveforms 
was measured automatically.
Statistical analysis
Statistical analyses were performed using Windows SPSS 
package (version 20.0, Chicago, IL, USA). Continuous variables 
were reported as mean±SD and categorical variables as fre-
quency and percentage. Chi-square test, Fisher exact test, and 
independent t test were used for comparisons. To determine the 
association between CMBs burden and AA, patients with CMBs 
were categorized into three groups according to number of 
CMBs (none, 1-2, and ≥3).26 Multivariable analysis was per-
formed using the factors with a P value <0.1 in the univariable 
analysis. Independent factors of presence of AAs were deter-
mined with binary logistic regression analysis. For the existence 
of CAP and SAP, multinomial logistic regression analysis was 
used with CAPs and SAPs as dependent variables. Because the 
variance inflation factor was higher than six among SVDs, each 
SVD and total SVD score were separately analyzed in multivari-
able analyses. Statistical significance was set at P<0.05. Odds 
ratios (OR) and 95% confidence interval (CI) were also calculated.
Results
Study patients
Among the 1,888 patients who were prospectively registered 
in the stroke data base, patients with transient ischemic attack 
(n=177), stroke due to other rare causes (n=45), and incom-
plete stroke evaluation (n=18) were excluded. Patients without 
evaluation by TEE (n=759), brain MRI (n=81), gradient recalled 
echo images (n=35), lack of vascular imaging studies (n=32), or 
poor image quality (n=4) were also excluded. Finally, a total of 
Figure 1. Illustrative imaging findings of cerebral small vessel diseases. (A) Cerebral microbleeds (arrows), (B) high-grade white matter hyperintesities 
(arrows), (C) high-grade perivascular spaces (arrows), and (D) asymptomatic lacunar infarction (arrows).
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737 patients were included (Supplemental Figure 3). Patients 
who underwent TEE were younger (P=0.001), more likely to be 
smokers (P=0.021), and less frequently had a history of stroke 
(P=  0.010) than those without TEE, although the other variables 
were similar between the groups (Supplementary Table 1).
Aortic atheroma and cerebral small vessel diseases
AA was found by TEE in 360 (48.8%) patients, including 11.6% 
with CAP and 37.2% with SAP. Patients with AA were older and 
included a higher proportion of males compared to those with-
out AA. Most risk factors, including hypertension, diabetes melli-
tus, hyperlipidemia, coronary artery disease, and metabolic syn-
drome were more common in patients with AA. In the TOAST 
classification, large artery atherosclerosis was similar between 
patients with AA and those without. Undetermined two or more 
causes identified were twice as common in patients with AA 
(27.2%) as those without (14.9%). The undetermined two or 
more causes identified subtypes were consisted of 59/98 (59.3%) 
with large artery atherosclerosis plus lacunar infarction, 19/98 
(19.4%) with large artery atherosclerosis plus cardioembolism, 
17/98 (17.3%) with lacunar infarction plus cardioembolism, and 
3/98 (3.0%) with large artery atherosclerosis plus lacunar infarc-
tion plus cardioembolism. Undetermined two or more causes 
identified subtype was more common in patients with CAP 
(57.0%) than those with SAP (17.9%) (Table 1). When we reclas-
sified TOAST classification, patients with CAP more frequently 
had large artery atherosclerosis or lacunar infarction than those 
with SAP and without AA (p=0.001) (Supplementary Table 2).
One or more types of SVDs were found in 269 (36.4%) pa-
tients, including 161 (21.8%) CMBs, 218 (29.6%) high-grade 
WMHs, 152 (20.6%) high-grade PVSs, and 230 (31.2%) ALIs. 
Among the patients with CMB, 153 (95.0%) had non-lobar 
CMBs, and 8 (5.0%) had strictly lobar CMBs, including 7 (4.3%) 
with probable CAA and 1 (0.7%) with possible CAA. Total SVD 
score=0 was found in 63.2% patients, 1 in 3.1%, 2 in 11.7%, 3 
in 11.1%, and 4 in 10.9%. A total SVD score of 1 was found in 23 
(3.1%) patients, who most commonly had only CMB (52.1%). In 
patients with a total SVD score of 2, the most common combi-
nation was high-grade WMH plus ALI in 86 patients (76.7%). For 
patients with a total SVD score of 3, CMB plus high-grade PVS 
plus ALI was most common and was found in 82 (40.2%) pa-
tients. Total SVD score was higher in patients with AA compared 
to those without and CAP compared to SAP (Table 2). 
All subtypes of SVDs were common in patients with AA and 
CAP (Table 2). Regarding the location of CMBs, strictly lobar and 
non-lobar CMBs were more common in patients with AA than in 
Table 1. Demographic characteristics of patients with aortic atheroma (AA)
Total  
(n=737)
AAs (+)  
(n=360)
AAs (-)  
(n=377)
P value CAPs 
(n=86)
SAPs 
(n=274)
P value*
Age (year) 63±12 66±9 59±13 0.001 69±8 65±9 0.001
Sex (male) 461 (62.6) 245 (68.1) 216 (57.3) 0.003 68 (79.1) 177 (64.6) 0.012
Risk factors
   Hypertension 580 (78.7) 302 (83.9) 278 (73.7) 0.001 69 (80.2) 233 (85.0) 0.314
   Diabetes Mellitus 248 (33.6) 146 (40.6) 102 (27.1) 0.001 37 (43.0) 109 (39.8) 0.593
   Hyperlipidemia 56 (7.6) 35 (9.7) 21 (5.6) 0.033 7 (8.1) 28 (10.2) 0.679
   Smoking 202 (27.4) 98 (27.2) 104 (27.6) 0.912 30 (34.9) 68 (24.8) 0.072
   Atrial fibrillation 125 (17.0) 62 (17.2) 63 (16.7) 0.853 14 (16.3) 48 (17.5) 0.949
   Metabolic syndrome 284 (38.5) 158 (43.9) 126 (33.4) 0.004 31 (36.0) 127 (46.4) 0.106
   Previous stroke 135 (18.3) 74 (20.6) 61 (16.2) 0.125 14 (16.3) 60 (21.9) 0.288
   Coronary artery disease 159 (21.6) 103 (28.6) 56 (14.9) 0.001 23 (26.7) 80 (29.2) 0.785
   Congestive heart failure 29 (3.9) 11 (3.1) 18 (4.8) 0.230 0 (0.0) 11 (4.0) 0.073
Previous medications
   Anti-platelet 199 (27.0) 104 (28.9) 95 (25.2) 0.259 32 (37.2) 72 (26.3) 0.057
   Anti-coagulant 51 (6.9) 29 (8.1) 22 (5.8) 0.235 5 (5.8) 24 (8.8) 0.498
   Lipid lowering agents 94 (12.8) 49 (13.6) 45 (11.9) 0.496 13 (15.1) 36 (13.1) 0.718
Stroke classification 0.001 0.001
  Large artery atherosclerosis 186 (25.2) 98 (27.2) 88 (23.3) 37 (43.0) 61 (22.3)
  Lacunar infarction 58 (7.9) 23 (6.4) 35 (9.3) 0 (0.0) 23 (8.4)
  Cardioembolism 174 (23.6) 70 (19.4) 104 (27.6) 0 (0.0) 70 (25.5)
  Undetermined two or more causes identified 154 (20.9) 98 (27.2) 56 (14.9) 49 (57.0) 49 (17.9)
  Undetermined due to negative evaluation 165 (22.4) 71 (19.7) 94 (24.9) 0 (0.0) 71 (25.9)
Values are number (%) or means±standard deviation.
AAs, aortic atheromas; CAPs, complex aortic plaques; SAPs, simple aortic plaques.
*Comparison between SAPs and CAPs.
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Table 2. Univariable analysis for association between aortic atheroma (AA) and cerebral small vessel diseases (SVDs)
Total
AAs (+)  
(n=360)
AAs (-)  
(n=377)
P value CAPs 
(n=86)
SAPs 
(n=274)
P value
Cerebral Microbleeds (CMBs)
  Presence 161 (21.8) 128 (35.6) 33 (8.8) <0.001 43 (50.0) 85 (31.0) 0.002
  Burden <0.001 0.002
     CMBs 1-2 83 (11.3) 68 (18.9) 15 (4.0) 26 (30.2) 42 (15.3)
     CMBs ≥  3 78 (10.6) 60 (16.7) 18 (4.8) 17 (19.8) 43 (15.7)
  Distribution <0.001 0.001
     Strictly lobar 8 (1.1) 6 (1.7) 2 (0.5) 4 (4.7) 2 (0.7)
     Non-lobar 153 (20.8) 122 (33.9) 31 (8.2) 39 (45.3) 83 (30.3)
High-grade white matter hyperintensities (WMHs) 218 (29.6) 158 (43.9) 60 (15.9) <0.001 49 (57.0) 109 (39.8) 0.006
   Periventricular WMHs 214 (29.0) 157 (43.6) 57 (15.1) <0.001 49 (57.0) 108 (39.4) 0.006
   Deep WMHs 176 (23.9) 130 (36.1) 46 (12.2) <0.001 43 (50.0) 87 (31.8) 0.002
High-grade perivascular spaces 152 (20.6) 115 (31.9) 37 (9.8) <0.001 40 (46.5) 75 (27.4) 0.001
Asymptomatic lacunar infarctions 230 (31.2) 173 (48.1) 57 (15.1) <0.001 52 (60.5) 121 (44.2) 0.009
Total SVD score <0.001 0.001
  0 466 (63.2) 168 (46.7) 298 (79.0) 28 (32.6) 140 (51.1)
  1 23 (3.1) 8 (2.2) 15 (4.0) 0 (0.0) 8 (2.9)
  2 86 (11.7) 52 (14.4) 34 (9.0) 17 (19.8) 35 (12.8)
  3 82 (11.1) 66 (18.3) 16 (4.2) 14 (16.3) 52 (19.0)
  4 80 (10.9) 66 (18.3) 14 (3.7) 27 (31.4) 39 (14.2)
Values are number (%) or means±SD.
AAs, aortic atheromas; CAPs, complex aortic plaques; SAPs, simple aortic plaques.
those without (P<0.001). Patients with CAP had high-grade 
WMHs in both periventricular and deep white matter regions. 
Number of CMBs, degree of WMHs, and degree of PVSs were 
highest in patients with CAP, followed by those with SAP, com-
pared to those without AA (P for trend <0.001). Moreover, CAP 
was more common as burden of total SVD score increased (P for 
trend <0.001) (Figure 2).
Multivariable analysis of presence of AA
Binary logistic regression analysis revealed that patients with 
AA were 4.68-fold (95% CI 3.01-7.28) more likely to have CMBs 
compared to those without. High-grade WMHs (OR 3.13, 95% 
CI 2.15-4.57), high-grade PVSs (OR 3.13, 95% CI 2.15-4.57), and 
presence of ALIs (OR 4.24, 95% CI 2.90-6.20) were also more 
common in patients with AA. Both periventricular and deep 
WMHs were common in patients with AA. Total SVD score ≥2 
was independently associated with presence of AA (Table 3). 
In multinomial logistic regression analysis, patients with CAP 
(OR 8.72, 95% CI 4.71-16.14) or SAP (OR 3.94, 95% CI 2.48-
6.25) more frequently had cerebral SVD. They also more com-
monly had all subtypes of SVDs. Regarding the location of CMBs, 
patients with CAP or SAP were more likely to have both non-lo-
bar and strictly lobar CMBs. In particular, patients with CAP were 
more likely to have strictly lobar CMBs. Total SVD score ≥2 was 
independently related with presence of CAP or SAP, and each 
1-point increase in total SVD score increased the odds of pres-
ence of CAP (OR 1.94, 95% CI 1.44-1.85) and SAP (OR 1.54 95% 
CI 1.35-1.75) (Table 3).
Sensitivity analysis of patients who underwent baPWV was 
conducted. Among total 737 patients, 143 patients who did not 
performe baPWV were excluded. Then, 174 patients who have 
potential cardiac sources of embolism were excluded because 
arrhythmia can prevent accurate measurement of baPWV and 
steno-occlusive lesions that can be indistinguishable from cardi-
ac embolism.28 Finally, 420 patients were included in subgroup 
analysis for relationship between AA and arterial stiffness. Re-
garding arterial stiffness, increased pulse wave velocity was as-
sociated with presence of AA and higher burden of AA (CAP) but 
not SAP (Supplementary Table 3).
When applying reclassification of the TOAST classification, in-
dex acute lacunar infarction was not related with presence of 
AA but there were trend of their association (OR 1.67, 95% CI 
0.93-2.99). Whereas the index lacunar infarction was indepen-
dently associated with CAP (OR 3.27, 95% CI 1.51-7.08) but not 
with SAP (OR 1.19, 95% CI 0.61-2.30) (Supplementary Table 4).
Discussion
We demonstrated that patients with AA not only frequently 
had coexisting SVDs, but also had a higher burden of coexisting 
SVDs as measured by total SVD score. Patients with AA had 
higher numbers of CMBs, higher grade WMHs, and higher grade 
PVSs compared to those without AA. Among subtypes of AAs, 
patients with CAP, and to a lesser extent those with SAP, had a 
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higher number of CMBs, a higher degree of WMHs, high-grade 
PVSs than those without AA.
Few studies have reported the association between AA and 
coexisting SVDs. As mentioned above, a case control study 
showed that presence of proximal AA was associated with lacu-
nar infarction.14 An autopsy study demonstrated that ulcerated 
plaque in the aortic arch was frequent in patients with crypto-
genic stroke. Nine of 17 patients with ulcerated plaque had la-
cunar infarction.4 Another study showed that AA evaluated by 
computed tomography angiography in patients with cryptogenic 
stroke was associated with SVDs.29 However, there is no study 
evaluating association between AA determined TEE and subtypes 
of SVDs and AA. In this study, index lacunar infarction was not 
associated with AA and frequency of lacunar infarction on the 
TOAST classification in our study was low. These findings might 
be caused by our classifying methods with the TOAST classifica-
tion. Using the TOAST classification, we considered CAPs as one 
of large artery atherosclerosis. Applying the reclassified TOAST 
classification when CAPs were not considered as one of large ar-
tery atherosclerosis, the index lacunar infarction was indepen-
dently associated with CAP but not with SAP. These findings 
suggest that AA are associated with both coexisting cerebral 
SVDs and index acute lacunar infarction.
Pathophysiologies of large artery atherosclerosis and SVDs in 
ischemic stroke are different. Plaque rupture and artery-to-artery 
embolism are major mechanisms in large artery atherosclerosis, 
whereas lipohyalinosis and parent artery atherosclerosis in 
SVDs.30 It is uncertain whether AA is merely coexistent or mech-
anistically connected with SVDs.14 Exact mechanism for the as-
sociation between burdens of AA and coexisting SVDs cannot be 
drawn from our study. Association between AA and SVDs in our 
study can be explained by the following hypotheses. First, in-
Figure 2. Association between aortic atheroma and burden of cerebral small vessel diseases. Number of CMBs (A), degree of high-grade WMH (B), 
degree of PVS (C), and total SVD score (D) were highest in patients with CAP, followed by those with SAP, compared to patients without AA (P for 
trend <0.001). AA, aortic atheroma; CMB, cerebral microbleed; SAP, simple aortic plaque; CAP, complex aortic plaque; WMH, white matter hyperin-
tensity; PVS, perivascular space; SVD, small vessel disease.
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57 (15.1)
41 (10.9)
19 (5.0)
106 (38.7)
59 (21.5)
66 (24.1)
43 (15.7)
24 (27.9)
13 (15.1)
30 (34.9)
19 (22.1)
No AA SAP CAP
D
Total SVD 0
Total SVD 1
Total SVD 2
Total SVD 3
Total SVD 4
14 (3.7)
298 (79.0)
15 (4.0)
34 (9.0)
16 (4.2)
28 (32.6)
17 (19.8)
14 (16.3)
27 (31.4)
140 (51.1)
8 (2.9)
35 (12.8)
52 (19.0)
39 (14.2)
320 (84.9)
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creased arterial stiffness which related with progressed AA may 
explain the results of our study. In previous studies, increased ar-
terial stiffness was positively associated with larger burden of 
AA.31,32 Arterial stiffness increases the pulse pressure and con-
tributes to systemic hypertensive injury.11 Previous studies 
showed that the presence of cerebral SVDs was correlated with 
increased augmentation index and pulse wave velocity which 
representing arterial stiffness.28,31,32 Because brain vessels have a 
low vascular resistance, SVDs are vulnerable to increased pulse 
pressure.11 In addition, increased arterial stiffness on CAP com-
paring with that of SAP in our study may be one of explanation 
of association with larger burden of AA and progressed SVDs. 
Second, large artery atherosclerosis and SVDs share common risk 
factors of ischemic stroke. Old age and chronic hypertension are 
associated with both AA and SVDs.33,34 Our study findings are in 
line with these previous studies. Although the TOAST subtype of 
large artery atherosclerosis was similar between patients with 
AA and those without, undetermined two or more causes (main-
ly large artery atherosclerosis and lacunar infarction) were twice 
as common in patients with AA. These findings suggest develop-
ment of stroke in patients with AAs may not be solely dependent 
on large artery atherosclerosis. Third, inflammatory processes 
play a key role in the development of both AA and SVDs. Patients 
with AA had a higher leukocyte count and higher levels of in-
flammatory cytokines.35 Similarly, patients with SVDs had higher 
levels of inflammatory markers.36 Lastly, SVDs can be derived 
from emboli itself caused by AA. A clinical study showed that 
microembolic signals in transcranial Doppler were frequent in 
patients with AA.37 Autopsy or clinical studies suggested that 
thrombotic or cholesterol emboli from ulcerated plaque in AA 
may cause SVDs.38 
Our study showed that AA was closely related to CMBs. In 
particular, we firstly demonstrated that strictly lobar CMBs was 
associated with CAP but not with SAP, whereas non-lobar CMBs 
was frequent in both CAP and SAP. Pathophysiology of CMBs is 
known to be different according to location. Non-lobar CMBs is 
regarded as hypertensive vasculopathy, whereas lobar CMBs is 
associated with CAA. Relationship between non-lobar CMBs and 
AA could be explained by their sharing classic vascular risk fac-
tors, including hypertension and high pulse pressure, or increased 
arterial stiffness.11,32 In contrast, the patients with strictly lobar 
CMBs may have risk factors of CAA.39 Because, exact mechanism 
for association between CAPs and strictly lobar CMBs cannot be 
identified in our study, further research is mandatory to solve it.
Our study also firstly demonstrated the association between 
PVSs and AA. A previous study showed that patients with PVSs 
were more likely to exhibit vascular dementia as opposed to Al-
zheimer disease.40 PVS was closely related with WMHs,41 in-
Table 3. Multivariable analysis for association between aortic atheroma (AA) and cerebral small vessel diseases (SVDs)
Binary logistic regression* Multinomial multivariate logistic regression*
Adjusted OR 
(95% CI) for AAs
P value Adjusted OR 
(95% CI) for CAPs
P value  Adjusted OR 
95% CI) for SAPs
P value
Cerebral microbleeds (CMBs)
Presence 4.68 (3.01-7.28) 0.001 8.72 (4.71-16.14) 0.001 3.94 (2.48-6.25) 0.001
Burden
    CMBs 1-2 5.54 (3.01-10.19) 0.001 12.46 (5.69-27.25) 0.026 4.38 (2.32-8.30) 0.013
    CMBs ≥  3 3.95 (2.19-7.11) 0.022 5.70 (2.49-13.03) 0.041 3.56 (1.94-6.53) 0.042
Distribution
    Non-lobar 4.61 (2.93-7.25) 0.017 7.88 (4.19-14.82) 0.037 3.99 (2.49-6.38) 0.004
    Strictly lobar 5.89 (1.07-33.24) 0.001 43.32 (5.36-349.54) 0.016 2.60 (0.34-19.77) 0.714
High-grade white matter hyperintensities (WMHs) 3.13 (2.15-4.57) 0.035 5.27 (2.96-9.37) 0.025 2.73 (1.84-4.05) 0.017
  Periventricular WMHs 3.31 (2.26-4.86) 0.031 5.35 (2.43-11.76) 0.021 2.87 (1.93-4.28) 0.012
  Deep WMHs 3.01 (2.00-4.53) 0.032 5.64 (3.08-10.35) 0.011 2.56 (1.67-3.92) 0.015
High-grade perivascular spaces 3.35 (2.17-5.17) 0.038 5.70 (3.19-10.19) 0.035 2.74 (1.75-4.31) 0.021
Asymptomatic lacunar infarctions 4.24 (2.90-6.20) 0.003 6.92 (3.88-12.34) 0.041 3.74 (2.51-5.56) 0.005
Total SVD score
   0 Reference Reference Reference
   1 0.74 (0.30-1.83) 0.521 No cases 0.76 (0.29-1.97) 0.580
   2 2.07 (1.24-3.44) 0.035 4.76 (2.01-11.28) 0.026 1.75 (1.03-3.03) 0.043
   3 6.46 (3.49-1.94) 0.038 10.38 (3.94-27.35) 0.041 5.91 (3.17-11.02) 0.032
   4 6.10 (3.21-11.62) 0.003 18.27 (7.07-47.18) 0.002 4.71 (2.40-9.25) 0.002
Total SVD score (per 1 point) 1.63 (1.44-1.85) 0.001 1.94 (1.62-2.32) 0.001 1.54 (1.35-1.75) 0.001
OR, Odds ratio; CI, confidence interval; AAs, aortic atheromas; CAPs, complex aortic plaques; SAPs, simple aortic plaques.
*No AAs as references. Adjusted by age, sex, hypertension, diabetes mellitus, hyperlipidemia, coronary artery disease, the prior antiplatelet medication, and 
stroke subtypes.
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creased blood-brain barrier permeability,42 and inflammatory re-
action.43 However, our results showed that grade of PVSs was 
associated with burden of AA, the reasons for this association 
remains uncertain. 
We firstly demonstrated that association between total SVD 
score and burden of AAs. Each component of SVD shares risk 
factors and mechanisms of developing stroke. In clinical applica-
tion, it is reasonable to consider various SVD with single repre-
sentative score. Total SVD score was used to evaluate overall ef-
fect of SVD on the brain, rather than estimating the effects of 1 
or 2 individual SVDs.27 Total SVD score was helpful for the rapid 
quantification or stratification of SVDs. Accordingly, our study 
gives new information about correlation in burdens of total SVD 
score and AA. 
Our study has limitations. First, although this study was per-
formed in the consecutive ischemic stroke patients who under-
went TEE, the possibility of selection bias exists due to the retro-
spective nature of the analysis. In our hospital, TEE was routine 
stroke evaluation based on the previous reports of usefulness of 
TEE in evaluation of potential cardiac or aortic source of embo-
lism.19,44 However, as routine evaluation of TEE may not be a 
common practice in other hospitals, it might be difficult to con-
firm our findings in those hospitals. Nonetheless, this is the larg-
est study that evaluated the association between TEE evaluated 
AA and SVDs. Second, strictly lobar CMBs were not confirmed by 
pathological study with presence of CAA. However, other studies 
were also conducted without pathologic confirmation.23 Third, 
small sample size of patients who had strictly lobar CMBs may 
result in statistical bias. Thus, the relationship between strictly 
lobar CMBs and CAP cannot be concluded. Therefore, caution 
must be needed when interpreting our results and further stud-
ies are required to identify our results. 
Conclusions
In this study, patients with AA frequently had coexisting cere-
bral SVDs. We also demonstrated that larger burden of AA was 
associated with coexisting advanced cerebral SVDs. Our findings 
give an additional information for positive relationship with sys-
temic atherosclerosis and coexisting cerebral SVDs in acute isch-
emic stroke patients.
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Supplementary methods
Transesophageal echocardiography (TEE)
Patients undergoing TEE fasted and received local pharyngeal 
anesthesia with 10% topical lidocaine prior to the examination. 
A commercially available TEE machine (iE33 xMATRIX, Philips) 
equipped with a multiplane 5-MHz transducer was used for the 
assessment of aortic atherosclerosis. TEE images were obtained 
using transgastric, midesophageal, and basal views. All segments 
of the thoracic aorta, including the ascending aorta, the aortic 
arch, and the descending aorta, were evaluated between 0 and 
90 degrees. AA was defined as a discrete protrusion of the inti-
mal surface of the aorta with different morphology and echo-
genicity. Plaque thickness was recorded as the whole thickness 
of the intima and media in the aortic wall and was measured 
perpendicularly in a frozen frame during systole.1
Risk factors and definitions of variables
Hypertension was diagnosed when a patient showed resting 
systolic blood pressure ≥140 mmHg or diastolic blood pressure 
≥90 mmHg in repeated measurements or was being treated 
with antihypertensive medication. Diabetes mellitus was diag-
nosed when a patient showed fasting blood glucose ≥7.0 mmol/
L or was being treated with antidiabetic medications. Hyperlipid-
emia was diagnosed when a patient had low-density lipoprotein 
cholesterol ≥4.1 mmol/L or total cholesterol ≥6.2 mmol/L. 
Smokers were defined as current smokers or individuals who had 
stopped smoking within one year before the current ischemic 
stroke. Presence of coronary artery disease was determined when 
a patient had a history of unstable angina, coronary artery oc-
clusive disease, or myocardial infarction. Metabolic syndrome 
was diagnosed when a patient had more than three components 
of abdominal obesity (waist circumference >102 cm for men, 
>88 cm for women); triglycerides ≥1.7 mmol/L; low level of 
high-density lipoprotein (<1.04 mmol/L for men, <1.30 mmol/L 
for women); or blood pressure greater than 130/85 mmHg; or 
fasting glucose ≥6.1 mmol/L.2,3
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Supplementary Table 1. Comparison between performed transesophageal echocardiography (TEE) or not performed
TEE (+) (n=737) TEE (-) (n=759) P value
Demographic data
Sex (male) 461 (62.6) 452 (59.6) 0.234
Age, years± standard deviation (SD) 63±12 67±12 0.001
Risk factors
Hypertension 580 (78.7) 622 (81.9) 0.113
Diabetes Mellitus 248 (33.6) 253 (33.3) 0.897
Hyperlipidemia 56 (7.6) 48 (6.3) 0.333
Smoking 202 (27.4) 169 (22.3) 0.021
Atrial fibrillation 125 (17.0) 128 (16.8) 0.960
Previous stroke 135 (18.3) 180 (23.7) 0.010
Coronary artery disease 159 (21.6) 148 (19.5) 0.321
Congestive heart failure 29 (3.9) 41 (5.4) 0.179
Metabolic syndrome 284 (38.5) 292 (38.5) 0.980
Previous medications
Anti-platelet 199 (27.0) 214 (28.2) 0.606
Anti-coagulant 51 (6.9) 57 (7.5) 0.659
Lipid lowing agents 94 (12.8) 97 (12.8) 0.988
Values are number (%) or means±SD.
Vol. 18 / No. 3 / September 2016
http://dx.doi.org/10.5853/jos.2016.00171 http://j-stroke.org
Supplementary Table 2. The frequency of stroke classification according to presence and burden of aortic atheromas (AAs) based on reclassified trial 
of ORG 10172 in acute stroke treatment (TOAST) classification*
AAs (-) 
(n=377)
AA (+) 
(n=360)
P value AAs (-)
(n=377)
CAPs 
(n=86)
SAPs
 (n=274)
P value
Reclassified TOAST classification 0.432 0.001
  Large artery atherosclerosis 88 (23.3) 86 (23.9) 88 (23.3) 25 (29.1) 61 (22.3)
  Lacunar infarction 35 (9.3) 47 (13.1) 35 (9.3) 24 (27.9) 23 (8.4)
  Cardioembolism 104 (27.6) 86 (23.9) 104 (27.6) 16 (18.6) 70 (25.5)
  Undetermined two or more causes identified 56 (14.9) 58 (16.1) 56 (14.9) 9 (10.5) 49 (17.9)
  Undetermined due to negative evaluation 94 (24.9) 83 (23.1) 94 (24.9) 12 (14.0) 71 (25.9)
Values are number (%).
OR, odds ratio; CI, confidence interval; AAs, aortic atheromas; CAPs, complex aortic plaques; SAPs, simple aortic plaques.
*CAP was not considered as large artery atherosclerosis component on TOAST classification.
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Supplementary Table 3. Multivariable analysis for determining presence of aortic atheroma (AA) after adjusting brachial ankle pulse wave velocity
Binary logistic regression* 
OR (95% CI)
Multinomial multivariate logistic regression* 
OR (95% CI)
AAs (n=210) P value CAPs (n=52) P value SAPs (n=158) P value
Age 1.06 (1.04-1.09) 0.001 1.11 (1.06-1.16) 0.001 1.05 (1.02-1.08) 0.001
Sex (male) 2.07 (1.29-3.32) 0.002 3.54 (2.73-6.48) 0.002 1.70 (1.23-2.62) 0.001
Hypertension 1.07 (0.58-1.98) 0.820 2.39 (0.94-6.07) 0.067 1.18 (0.72-1.89) 0.522
Diabetes Mellitus 1.61 (0.97-2.65) 0.062 1.82 (0.84-3.94) 0.125 1.37 (0.96-1.78) 0.058
Hyperlipidemia 1.73 (0.78-3.86) 0.174 1.73 (0.57-4.34) 0.220 1.69 (0.95-3.63) 0.075
Coronary artery disease 2.28 (1.33-3.92) 0.003 1.28 (0.55-2.96) 0.556 1.82 (1.37-2.84) 0.005
Metabolic syndrome 1.13 (0.67-1.90) 0.627 1.24 (0.65-1.68) 0.483 1.32 (0.84-1.98) 0.214
Previous anti-platelet 1.98 (1.04-3.65) 0.038 0.91 (0.62-1.43) 0.426
Stroke classification
Large artery atherosclerosis Reference Reference Reference
Lacunar infarction 1.12 (0.59-2.57) 0.502 No cases 1.01 (0.53-1.93) 0.455
Undetermined due to two or   
   more causes identified
0.78 (0.53-1.21) 0.125 1.67 (0.92-2.38) 0.082 0.82 (0.38-1.78) 0.625
Undetermined due to negative  
   evaluation
1.21 (0.75-1.97) 0.184 No cases 1.07 (0.72-1.84) 0.826
Pulse wave velocity (m/s) 1.02 (1.00-1.04) 0.047 1.03 (1.01-1.05) 0.037 1.01 (0.97-1.01) 0.223
Number of patients for subgroup analysis: 420.
OR, odds ratio; CI, confidence interval; AAs, aortic atheromas; CAPs, complex aortic plaques; SAPs, simple aortic plaques.
*No AAs as reference.
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Supplementary Table 4. Multivariable analysis for determining presence of aortic atheroma (AA) after adjusting reclassified trial of ORG 10172 in 
acute stroke treatment (TOAST) classification*
Binary logistic regression† 
OR (95% CI) 
Multinomial multivariate logistic regression† 
OR (95% CI)
AAs P value CAPs P value SAPs P value
Age 1.06 (1.04-1.07) 0.001 1.11 (1.07-1.14) 0.001 1.04 (1.03-1.06) 0.001
Sex (male) 2.09 (1.49-2.92) 0.001 4.23 (2.30-7.78) 0.001 1.73 (1.21-2.45) 0.002
Hypertension 1.10 (0.72-1.69) 0.647 0.78 (0.39-1.57) 0.494 1.22 (0.77-1.94) 0.379
Diabetes Mellitus 1.55 (1.08-2.22) 0.017 1.96 (1.10-3.49) 0.022 1.45 (0.99-2.13) 0.052
Hyperlipidemia 1.82 (0.99-3.36) 0.053 2.14 (0.80-5.72) 0.127 1.77 (0.94-3.33) 0.073
Coronary artery disease 1.73 (1.17-2.56) 0.005 1.35 (0.73-2.50) 0.331 1.84 (1.24-2.76) 0.003
Metabolic syndrome 1.17 (0.81-1.70) 0.398 0.80 (0.43-1.50) 0.502 1.27 (0.86-1.88) 0.214
Previous anti-platelet 2.14 (1.05-4.08) 0.037 0.93 (0.65-1.46) 0.538
Stroke classification
Large artery atherosclerosis Reference Reference Reference
Lacunar infarction 1.67 (0.93-2.99) 0.081 3.27 (1.51-7.08) 0.003 1.19 (0.61-2.30) 0.602
Cardioembolism 0.88 (0.55-1.39) 0.588 0.48 (0.22-1.02) 0.058 1.03 (0.63-1.68) 0.880
Undetermined due to two or more  
   causes identified
1.11 (0.71-1.76) 0.628 0.61 (0.25-1.50) 0.286 1.35 (0.79-2.32) 0.269
Undetermined due to negative  
   evaluation
1.16 (0.69-1.95) 0.556 0.54 (0.24-1.21) 0.136 1.32 (0.82-2.14) 0.245
OR, odds ratio; CI, confidence interval; AAs, aortic atheromas; CAPs, complex aortic plaques; SAPs, simple aortic plaques.
*CAP was not considered as large artery atherosclerosis component on TOAST classification; †No AAs as reference.
Jung S,et al. The Effect of the Evolvement of ERT in Acute BAO
http://dx.doi.org/10.5853/jos.2016.00171 http://j-stroke.org
Supplementary Figure 1. Left arrow: acute infarction on the right basal ganglia in diffusion-weighted imaging. Right white ring: hemorrhagic trans-
formation or cerebral microbleeds on gradient echo imaging. This hypointense lesion was not considered a cerebral microbleed because this area was 
overlapped with the acute infarction area.
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Supplementary Figure 2. Classification of white matter changes according to acute infarction. In patients with acute left middle cerebral artery terri-
tory infarction, the left side white matter changes were not classified as “white matter hyperintensity (WMH)” because this area was overlapped with 
the acute infarction area. In contrast, the right side white matter changes were regarded as high-grade periventricular WMH and a cavitary lesion on 
right side were classified as an asymptomatic lacunar infarction (ALI).
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Supplementary Figure 3. Flowchart of participants according to inclu-
sion and exclusion criteria.
Patients with cerebral infarction or 
transient ischemic attack who were 
admitted within 7 days of symptom onset
N=1,888
Finally, 737 patients  were enrolled
Transient ischemic attack
N=177
Stroke due to rare causes
N=45
Incomplete stroke evaluation
N=18
No brain MRI, N=81
No brain angiography, N=32
No GRE, N=35
Poor image of GRE quality, N=4
Not performed TEE
N=759
